Summary It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM 149 and JM335, which are the cis and trans geometry respectively of ammine (cyclohexylamine) 
Apoptosis is a biological mechanism by which cells undergo programmed cell death. Many chemotherapeutic agents of disparate mechanisms of action engage this conserved cellular response, including etoposide (Liu, 1989) , camptothecin (Kaufmann, 1989) , dexamethasone (Cohen et al., 1992; Wood et al., 1994) and taxol . It is thought that apoptosis may be the major mechanism through which drugs mediate their cytotoxic effects (Hickman, 1992; Kerr et al., 1994) . Furthermore, it has been proposed that tumour sensitivity and resistance to such drugs (and thus clinical outcome) may, at least in part, be attributable to the degree of activation of a genetic programme for cell death (Dive and Hickman, 1991) .
Cisplatin has been shown to induce apoptosis in a number of different cell lines including Chinese hamster ovarian cells, immature rat thymocytes, rat hepatoma cells and L1210 murine leukaemic cells Sorenson et al., 1990; Evans and Dive, 1993; Ormerod et al., 1994a) . In recent studies, the kinetics of cisplatin-induced apoptosis have been measured in vivo in mammary and ovarian adenocarcinomas in rodents . We have demonstrated that cisplatin induced apoptosis in three human ovarian carcinoma cell lines, the CH1, the acquired resistant CHlcisR and the intrinsically resistant SKOV-3 without concomitant internucleosomal cleavage (Ormerod et al., 1994b; Ormerod et al., 1996) . The resistance factors for CHlcisR and SKOV-3 following a 2 h exposure to cisplatin were 3-and 13-fold respectively (O'Neill et al., 1995) with equitoxic concentrations of drug required to induce similar levels of apoptosis (Ormerod et al., 1996) . Furthermore, we observed that apoptosis was the major mode of cell death, occurring at concentrations ranging from the physiologically relevant ICso (the dose required to give 50% growth inhibition) to 10 times this dose. In the data presented here we have extended these studies to new platinum drugs. The work centres on two novel platinum compounds, JM149 and JM335, which are cis and trans analogues respectively of ammine(cyclohexylamine)dihydroxodichloroplatinum(IV). These drugs have been synthesised as part of a drug discovery programme aimed at identifying more effective platinum-based anti-cancer drugs. Recent studies have shown that JM335 exhibited a different pattern of cross-resistance from JM149 in an in vitro panel of sensitive and resistant cell lines . Furthermore, preliminary DNA binding studies in the SKOV-3 cell line demonstrated that, at equimolar concentrations, more Pt was bound to DNA with JM335 than with JM149. Moreover, JM335 like cisplatin also formed interstrand cross-links (ISC) which are thought to be the most cytotoxic of Pt/DNA lesions formed (Zwelling et al., 1981; Hansson et al., 1988) , while JM149 did not. In contrast to this, in the CHI cell line, while JM149 initiated very low levels of ISC formation, these were undetectable following equimolar concentrations of JM335, which instead caused DNA strand breaks (Mellish et al., 1995 Measurement of platinum bound to DNA Following a 2 h incubation with equimolar concentrations of JM149 and JM335, DNA was extracted using the phenol method as previously described (O'Neill et al., 1995) . Dried DNA pellets were dissolved overnight at 37°C in 0.2% nitric acid and platinum content measured by flameless atomic absorption spectroscopy (FAAS) using a Perkin Elmer 1100B/HGA 700. DNA content was measured using the Burton assay, a colorimetric method which quantitates 2'-deoxyribose units (Burton, 1956 Morphology and viability of attached and detached cells The morphology of attached and detached cells was examined by light and electron microscopy 24 h following a 2 h incubation with 2 x and 10 x IC50 of JM149 and JM335. The attached cells remaining after incubation with 2 x IC50 of JM149 showed no evidence of chromatin condensation associated with apoptosis, with the chromatin remaining similar in appearance to that of control untreated cells (Figure 5a and b) . On the other hand while the majority of the attached cells remaining after 2 x IC50 of JM335 exhibited normal morphology, there was evidence that some apoptosis had taken place in that there were a small number of cells showing evidence of chromatin condensation (arrowed on Figure 5c ). At 2 x IC50 of both drugs the majority of detached cells exhibited the morphology consistent with apoptosis, displaying the characterisatic condensation and fragmentation pattern of chromatin around the periphery of the nucleus (Figure 5d and e). At 10 x IC50 of JM149, the detached cells were again apoptotic in appearance (Figure 5f and Figure 6a ), however, in contrast to this, the detached cells induced by the trans complex, JM335, at this concentration did not exhibit morphology associated with apoptosis ( Figure 5g and Figure 6b ). The chromatin was not condensed and resembled that of the attached cells. Moreover, there was evidence of extensive vesiculation in these cells which could be seen more clearly upon closer examination by electron microscopy ( Figure 6b (Figure 7 ). This fragment was also absent from the attached cells at all concentrations of both drugs. Furthermore, internucleosomal cleavage could not be detected in the cells undergoing apoptosis (data not shown).
Cell cycle analysis Flow cytometric analysis of the effects of 2 x and 5 x IC50 Of JM149 and JM335 on the progression of cells through the cell cycle was carried out on attached cells only. The DNA histograms indicated that the main effect of both concentrations of JM149 and 2 x IC50 of JM335 was a slowdown of passage through S-phase (Figure 8) as evidenced by the increase in the percentage of cells in this phase of the cell cycle by 16 h and 24 h following removal of drug (Figure 9) . By 24 h, cells exposed to 2 x IC50 of JM335 and 5 x IC50 Of JM149 had not progressed beyond early S-phase, while those (a) bar 2,um; (b) bar 4pgm. et al., 1994) to induce apoptosis in the CHI human ovarian carcinoma cell line. This cell line has previously been shown to be relatively sensitive to cisplatin (e.g. Kelland et al., 1994) and to undergo apoptosis following exposure to physiologically relevant concentrations of cisplatin (Ormerod et al., 1994b (Ormerod et al., , 1996 . Following a 2 h exposure to various concentrations of cisplatin, cells rounded up and detached from the monolayer in a time-and dose-dependent manner with the majority of cells detaching at between 24 and 48 h following removal of drug. Electron and light microscopy revealed that the detached cells from both CHI cell lines displayed typical morphological features of apoptosis with the DNA degraded into fragments of 30-50 kb in size. The major cell cycle effect appeared to be S-phase slowdown with a comparatively small G2 block. Studies have shown that CHI cells possess a wild-type p53 gene sequence, which is induced approximately 5-fold following 5 Gy gammairradiation and express Bcl-2 protein (Beale et al., 1996) . Both platinum-based isomers induced apoptosis in this cell line at 2 x IC50, a concentration which is roughly equivalent to a 95% inhibition of cell growth. The detached cells elicited by the two drugs exhibited fragmentation and condensation of chromatin around the periphery of the nuclear membrane ( Figure Sd and e) consistent with the morphology of apoptosis (Wyllie, 1980; Arends et al., 1990; Arends and Wyllie 1991) . That apoptosis.had indeed occurred was further substantiated by the presence of a 50 kb DNA fragment (Walker et al., 1991; Oberhammer et al., 1993; Brown et al., 1993; Ormerod et al., 1994b and observed in the only in the detached cell population. In striking contrast to this, the trans isomer JM335 did not induce apoptosis at 10 x IC50. The chromatin of the detached cells remained normal in appearance with no morphological evidence of apoptosis having taken place (Figure 5g ). Moreover, no 50 kb DNA fragment or fragments of a similar size were detected on FIGE (Figure 7) . to the onset of apoptosis, whereas at 2 x IC50 of JM335 the phase of the cell rate of induction of apoptosis is almost linear (Figure 4b ). a 2 exposure to Moreover, while at 2 x IC50 of JM 149 there was a measurable closed symbols, increase in the number of attached cells up to 24 h, no increase in the attached cell population was observed with either concentration of JM335 (Figure 4a) . However, at 24 h after drug incubation the combined totals for attached and IE (Figure 7) .0 E 5 strand breaks in the CH1 cells following 2-4 h drug exposure to 25 and 100 gM (Mellish et al., 1995) . In contrast, Pt -DNA interstrand cross-links were measurable in CHl cells following exposure to JM149 (25 or 100 pmx 4 h), but not with JM335. Moreover, the nature of intrastrand cross-links induced by the two drugs appear to differ; a monoclonal antibody raised against cisplatin-treated DNA (and thought to recognise the major 1,2 G-G intrastrand adduct induced by cisplatin) recognised DNA adducts in CHl cells produced by JM149 exposure but not by JM335 (Mellish et al., 1995) . These comparative DNAbinding properties suggest that the slower rate of induction of apoptosis with the cis complex JM149, may relate to a requirement for the conversion of cross-links to strand breaks in order to generate an apoptotic response. This may be at least partially addressed through investigations of p53 protein induction in this cell line by these two drugs.
Other observations made in freshly isolated rat thymocytes showed that, in contrast to agents such as etoposide which directly induce DNA strand breaks and which readily induced apoptosis, cisplatin-induced apoptosis may need to be coupled to a cell cycle-mediated event (Evans and Dive, 1993) . Thus this may also apply for JM149 but not for JM335 (which induces strand breaks directly in this line).
A recent study has shown that B-cell human lymphoma cells which underwent apoptosis at comparatively low concentrations of idarubicin and doxorubicin failed to do so at higher concentrations of these drugs (Smith et al., 1994) . It was proposed that, at high concentrations of drug, a failure to traverse S-phase was associated with the failure of these cells to engage the process of apoptosis. Previous studies from our group have shown that the main cell cycle effect of cisplatin on CH1 cells was a slowdown in S-phase transit with apoptosis occurring predominantly, although not exclusively, from this phase of the cell cycle (Ormerod et al., 1996) . Other investigations have shown that cisplatin induces apoptosis in all phases of the cell cycle in some cell types (HL-60 cells) (Gorczyca et al., 1993) . Our observations show that the cell cycle effects of JM149 and JM335 were similar to those observed with cisplatin in that the main feature was a slowdown in the passage of cells through S-phase. By 24 h cells were detained in either early S-phase (2 x and 5 x IC50 Of JM335 and JM149 respectively) or late S-phase (2 x IC50 JM149) (Figure 8 ). There was no evidence of a G2/M block at 24 h at these concentrations and therefore it is likely that apoptosis occurred mainly from cells in S-phase. On the other hand, following exposure of the CHI cell line to 5 x IC50 Of JM335, cells appeared almost frozen in the cell cycle with evidence of a build-up of cells in G2 indicative of a G2/M block. The DNA histograms in Figure 8 give the impression that the majority of cells were prevented from cycling and were dying from all phases of the cell cycle. Thus the inability of these cells to progress effectively from one phase of the cell cycle to another at this concentration of JM335 may be the reason for their failure to engage apoptosis.
In conclusion we have shown that JM149 and JM335 induced apoptosis in the CHI cell line at equitoxic and physiologically relevant concentrations of drug and that the kinetics of apoptosis was more rapid with the trans compound JM335. This may relate to differences in DNA adduct formation by these two isomers. However, at high concentrations (10 x IC50) of JM335, CHI cells fail to undergo apoptosis and cell death occurs by an alternative method.
